

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of protein localization to Golgi (GO:0072600) | 5.01089806 |
| 2 | interkinetic nuclear migration (GO:0022027) | 4.49290330 |
| 3 | nuclear pore complex assembly (GO:0051292) | 4.46930590 |
| 4 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.45406790 |
| 5 | protein targeting to Golgi (GO:0000042) | 4.29540001 |
| 6 | negative regulation of vascular permeability (GO:0043116) | 4.26360865 |
| 7 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.05849576 |
| 8 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.99908321 |
| 9 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.93378260 |
| 10 | thrombin receptor signaling pathway (GO:0070493) | 3.82053144 |
| 11 | nuclear pore organization (GO:0006999) | 3.71026696 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.65595775 |
| 13 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.56900641 |
| 14 | artery development (GO:0060840) | 3.54341962 |
| 15 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.50347281 |
| 16 | positive regulation of muscle hypertrophy (GO:0014742) | 3.48556559 |
| 17 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.48556559 |
| 18 | protein K48-linked deubiquitination (GO:0071108) | 3.45735639 |
| 19 | pore complex assembly (GO:0046931) | 3.37347575 |
| 20 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.35286557 |
| 21 | negative regulation of protein localization to cell surface (GO:2000009) | 3.32326155 |
| 22 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.30176905 |
| 23 | regulation of lipoprotein metabolic process (GO:0050746) | 3.29472093 |
| 24 | carnitine shuttle (GO:0006853) | 3.28216435 |
| 25 | early endosome to late endosome transport (GO:0045022) | 3.24324699 |
| 26 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.22175527 |
| 27 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.21049422 |
| 28 | sleep (GO:0030431) | 3.00569792 |
| 29 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.99364671 |
| 30 | keratinization (GO:0031424) | 2.95956475 |
| 31 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.88827669 |
| 32 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.87117127 |
| 33 | COPII vesicle coating (GO:0048208) | 2.87107146 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 2.87106117 |
| 35 | macroautophagy (GO:0016236) | 2.86564233 |
| 36 | regulation of endothelial cell differentiation (GO:0045601) | 2.85206752 |
| 37 | microtubule nucleation (GO:0007020) | 2.83928412 |
| 38 | fibroblast migration (GO:0010761) | 2.83914740 |
| 39 | microtubule anchoring (GO:0034453) | 2.83561188 |
| 40 | regulation of cell communication by electrical coupling (GO:0010649) | 2.83329470 |
| 41 | negative regulation of neurotransmitter transport (GO:0051589) | 2.82382750 |
| 42 | positive regulation of glycolytic process (GO:0045821) | 2.82147828 |
| 43 | lymphangiogenesis (GO:0001946) | 2.78553575 |
| 44 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.78030815 |
| 45 | protein localization to Golgi apparatus (GO:0034067) | 2.77102970 |
| 46 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.75664397 |
| 47 | regulation of establishment of cell polarity (GO:2000114) | 2.74702009 |
| 48 | Golgi to plasma membrane protein transport (GO:0043001) | 2.72570668 |
| 49 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.71059595 |
| 50 | microtubule depolymerization (GO:0007019) | 2.71006730 |
| 51 | cyclic nucleotide catabolic process (GO:0009214) | 2.68347533 |
| 52 | desmosome organization (GO:0002934) | 2.66529685 |
| 53 | biotin metabolic process (GO:0006768) | 2.63581182 |
| 54 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.63534959 |
| 55 | mesodermal cell differentiation (GO:0048333) | 2.61999197 |
| 56 | nucleus localization (GO:0051647) | 2.61455394 |
| 57 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.60684654 |
| 58 | negative regulation of blood circulation (GO:1903523) | 2.58124722 |
| 59 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.58019416 |
| 60 | establishment of skin barrier (GO:0061436) | 2.57457765 |
| 61 | Golgi to plasma membrane transport (GO:0006893) | 2.57449053 |
| 62 | regulation of pigment cell differentiation (GO:0050932) | 2.54221072 |
| 63 | regulation of muscle hypertrophy (GO:0014743) | 2.52719393 |
| 64 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.52234282 |
| 65 | regulation of female receptivity (GO:0045924) | 2.52029664 |
| 66 | Golgi to endosome transport (GO:0006895) | 2.49532733 |
| 67 | musculoskeletal movement (GO:0050881) | 2.48512402 |
| 68 | multicellular organismal movement (GO:0050879) | 2.48512402 |
| 69 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.47725086 |
| 70 | regulation of glycolytic process (GO:0006110) | 2.45964297 |
| 71 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.44327624 |
| 72 | regulation of relaxation of muscle (GO:1901077) | 2.43367144 |
| 73 | regulation of sarcomere organization (GO:0060297) | 2.42383405 |
| 74 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.41900127 |
| 75 | phospholipid translocation (GO:0045332) | 2.41228843 |
| 76 | lipid translocation (GO:0034204) | 2.41228843 |
| 77 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.40701185 |
| 78 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.39871787 |
| 79 | receptor recycling (GO:0001881) | 2.39724090 |
| 80 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.38919424 |
| 81 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.38919424 |
| 82 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.38919424 |
| 83 | regulation of protein localization to cell surface (GO:2000008) | 2.38581636 |
| 84 | carnitine transmembrane transport (GO:1902603) | 2.37656513 |
| 85 | linoleic acid metabolic process (GO:0043651) | 2.37250823 |
| 86 | regulation of energy homeostasis (GO:2000505) | 2.36736005 |
| 87 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.36439773 |
| 88 | regulation of alkaline phosphatase activity (GO:0010692) | 2.36431483 |
| 89 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.34891471 |
| 90 | microtubule polymerization or depolymerization (GO:0031109) | 2.34849400 |
| 91 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.34665559 |
| 92 | protein K11-linked deubiquitination (GO:0035871) | 2.33934988 |
| 93 | cAMP catabolic process (GO:0006198) | 2.31162866 |
| 94 | genitalia morphogenesis (GO:0035112) | 2.30602480 |
| 95 | vesicle transport along microtubule (GO:0047496) | 2.30330671 |
| 96 | regulation of muscle adaptation (GO:0043502) | 2.29597987 |
| 97 | protein K63-linked deubiquitination (GO:0070536) | 2.28630377 |
| 98 | coronary vasculature morphogenesis (GO:0060977) | 2.27433389 |
| 99 | amino-acid betaine transport (GO:0015838) | 2.24825973 |
| 100 | carnitine transport (GO:0015879) | 2.24825973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.99756729 |
| 2 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.00922829 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99776488 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.95755362 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.64196517 |
| 6 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.53384357 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.48409614 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.46681886 |
| 9 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.34590758 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.34291356 |
| 11 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.28461880 |
| 12 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.22893522 |
| 13 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.17505950 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02317591 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.97393495 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92724354 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.90128647 |
| 18 | STAT3_23295773_ChIP-Seq_U87_Human | 1.88391601 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77749459 |
| 20 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.75796543 |
| 21 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.68789528 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65839155 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65144170 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64492588 |
| 25 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.63923420 |
| 26 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.63877426 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63869210 |
| 28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63296692 |
| 29 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.60390293 |
| 30 | TCF4_23295773_ChIP-Seq_U87_Human | 1.58604323 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.58283000 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54303892 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54261470 |
| 34 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.53466456 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51749811 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48472797 |
| 37 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.47802880 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46356001 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46290005 |
| 40 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.45117959 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43980573 |
| 42 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42201294 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41489906 |
| 44 | TP53_16413492_ChIP-PET_HCT116_Human | 1.39627356 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37463454 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36144743 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36144743 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34420321 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34251868 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34113981 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34113981 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33823986 |
| 53 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.28574653 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26027812 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25367208 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25203670 |
| 57 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.25125853 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23732226 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20743514 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20464189 |
| 61 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20376915 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19611825 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19475441 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18103328 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18024826 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16588422 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14620138 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14114362 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12961848 |
| 70 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12812468 |
| 71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.12226456 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11894389 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10436118 |
| 74 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08667142 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08551725 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08345916 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08069012 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07333992 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.06752614 |
| 80 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05210507 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04042199 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03542048 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03138288 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02633447 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02535539 |
| 86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02171259 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01376990 |
| 88 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01376990 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01259274 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01207995 |
| 91 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01194826 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01055734 |
| 93 | TBL1_22424771_ChIP-Seq_293T_Human | 1.00506930 |
| 94 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.00133525 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97948403 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95921829 |
| 97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95830368 |
| 98 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95696952 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95188908 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95052186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010352_gastrointestinal_tract_polyps | 3.99938704 |
| 2 | MP0002009_preneoplasia | 3.82924720 |
| 3 | MP0008057_abnormal_DNA_replication | 3.18538793 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.17887725 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.09753396 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.08661989 |
| 7 | MP0003646_muscle_fatigue | 3.08350048 |
| 8 | MP0009697_abnormal_copulation | 2.94326300 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 2.61683404 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.50623289 |
| 11 | MP0004130_abnormal_muscle_cell | 2.35014260 |
| 12 | MP0003941_abnormal_skin_development | 2.22558157 |
| 13 | MP0005409_darkened_coat_color | 2.22044714 |
| 14 | MP0004510_myositis | 2.13967275 |
| 15 | MP0004233_abnormal_muscle_weight | 2.12157911 |
| 16 | MP0001879_abnormal_lymphatic_vessel | 2.08295386 |
| 17 | MP0008004_abnormal_stomach_pH | 2.05209360 |
| 18 | MP0005670_abnormal_white_adipose | 2.02256243 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.02224635 |
| 20 | MP0004484_altered_response_of | 1.86198662 |
| 21 | MP0005187_abnormal_penis_morphology | 1.85662365 |
| 22 | MP0005083_abnormal_biliary_tract | 1.81462161 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.75917193 |
| 24 | MP0000383_abnormal_hair_follicle | 1.70774485 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.64057681 |
| 26 | MP0001661_extended_life_span | 1.57664864 |
| 27 | MP0004134_abnormal_chest_morphology | 1.56832449 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.56642112 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.55804584 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.54049657 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.53202766 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.53187061 |
| 33 | MP0005275_abnormal_skin_tensile | 1.50489468 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.49761530 |
| 35 | MP0009046_muscle_twitch | 1.48460716 |
| 36 | MP0006138_congestive_heart_failure | 1.45931661 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.45745994 |
| 38 | MP0003879_abnormal_hair_cell | 1.45458432 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.43424158 |
| 40 | MP0003868_abnormal_feces_composition | 1.40956140 |
| 41 | MP0003045_fibrosis | 1.37477841 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.34975278 |
| 43 | MP0005365_abnormal_bile_salt | 1.33578545 |
| 44 | MP0004270_analgesia | 1.29776674 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.28013038 |
| 46 | MP0004085_abnormal_heartbeat | 1.27381355 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.27143005 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.26817975 |
| 49 | MP0010678_abnormal_skin_adnexa | 1.20966124 |
| 50 | MP0003828_pulmonary_edema | 1.20163125 |
| 51 | MP0009115_abnormal_fat_cell | 1.20006147 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.15417953 |
| 53 | MP0000230_abnormal_systemic_arterial | 1.13637409 |
| 54 | MP0005620_abnormal_muscle_contractility | 1.13264268 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.12733484 |
| 56 | MP0000427_abnormal_hair_cycle | 1.07100291 |
| 57 | MP0005410_abnormal_fertilization | 1.06301625 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.05637281 |
| 59 | MP0001486_abnormal_startle_reflex | 1.05360672 |
| 60 | MP0002972_abnormal_cardiac_muscle | 1.04235764 |
| 61 | MP0003890_abnormal_embryonic-extraembry | 1.04190754 |
| 62 | MP0002106_abnormal_muscle_physiology | 1.01977256 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.01016668 |
| 64 | MP0004924_abnormal_behavior | 0.98981755 |
| 65 | MP0005386_behavior/neurological_phenoty | 0.98981755 |
| 66 | MP0004087_abnormal_muscle_fiber | 0.95181771 |
| 67 | MP0003718_maternal_effect | 0.93976226 |
| 68 | MP0004272_abnormal_basement_membrane | 0.92289488 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.91518505 |
| 70 | MP0000733_abnormal_muscle_development | 0.89836603 |
| 71 | MP0002971_abnormal_brown_adipose | 0.89368192 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.87845251 |
| 73 | MP0001299_abnormal_eye_distance/ | 0.87376797 |
| 74 | MP0000647_abnormal_sebaceous_gland | 0.85779740 |
| 75 | MP0005385_cardiovascular_system_phenoty | 0.84497990 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 0.84497990 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.81625794 |
| 78 | MP0005369_muscle_phenotype | 0.78908801 |
| 79 | MP0001765_abnormal_ion_homeostasis | 0.75561508 |
| 80 | MP0002796_impaired_skin_barrier | 0.75531585 |
| 81 | MP0001784_abnormal_fluid_regulation | 0.75467384 |
| 82 | MP0001191_abnormal_skin_condition | 0.75122189 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 0.74914510 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.71464152 |
| 85 | MP0000749_muscle_degeneration | 0.71388356 |
| 86 | MP0000249_abnormal_blood_vessel | 0.71366569 |
| 87 | MP0004147_increased_porphyrin_level | 0.69100759 |
| 88 | MP0002006_tumorigenesis | 0.69064805 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 0.68070749 |
| 90 | MP0000759_abnormal_skeletal_muscle | 0.66565316 |
| 91 | MP0001851_eye_inflammation | 0.66343739 |
| 92 | MP0002128_abnormal_blood_circulation | 0.64096261 |
| 93 | MP0005266_abnormal_metabolism | 0.63285542 |
| 94 | MP0003633_abnormal_nervous_system | 0.62485201 |
| 95 | MP0010630_abnormal_cardiac_muscle | 0.61472879 |
| 96 | MP0003984_embryonic_growth_retardation | 0.59472943 |
| 97 | MP0002086_abnormal_extraembryonic_tissu | 0.58920360 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.58014775 |
| 99 | MP0005165_increased_susceptibility_to | 0.57249065 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.56627671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 5.02278908 |
| 2 | Increased mean platelet volume (HP:0011877) | 3.49906060 |
| 3 | Nemaline bodies (HP:0003798) | 3.44648578 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 3.44427842 |
| 5 | Menorrhagia (HP:0000132) | 3.44394289 |
| 6 | Tubulointerstitial nephritis (HP:0001970) | 3.26981023 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.10096903 |
| 8 | Acanthocytosis (HP:0001927) | 3.06566392 |
| 9 | Hyperkalemia (HP:0002153) | 3.03661446 |
| 10 | Papilledema (HP:0001085) | 3.01204752 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 3.01165608 |
| 12 | Prolonged bleeding time (HP:0003010) | 2.93435473 |
| 13 | Petechiae (HP:0000967) | 2.92673835 |
| 14 | Abnormal platelet volume (HP:0011876) | 2.92196357 |
| 15 | Overgrowth (HP:0001548) | 2.87904852 |
| 16 | Thyroid carcinoma (HP:0002890) | 2.69948373 |
| 17 | Subaortic stenosis (HP:0001682) | 2.67255007 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.67255007 |
| 19 | Truncal obesity (HP:0001956) | 2.67181573 |
| 20 | Genetic anticipation (HP:0003743) | 2.64430793 |
| 21 | Bundle branch block (HP:0011710) | 2.58324210 |
| 22 | Abnormal auditory evoked potentials (HP:0006958) | 2.57495247 |
| 23 | Acute myeloid leukemia (HP:0004808) | 2.57363296 |
| 24 | Neonatal hypoglycemia (HP:0001998) | 2.54589919 |
| 25 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.53165698 |
| 26 | Gingival bleeding (HP:0000225) | 2.50918404 |
| 27 | Fair hair (HP:0002286) | 2.50392829 |
| 28 | Renal cortical cysts (HP:0000803) | 2.45470688 |
| 29 | Sudden death (HP:0001699) | 2.44168447 |
| 30 | Medulloblastoma (HP:0002885) | 2.43670229 |
| 31 | Hyperventilation (HP:0002883) | 2.43180208 |
| 32 | Termporal pattern (HP:0011008) | 2.41226523 |
| 33 | Insidious onset (HP:0003587) | 2.41226523 |
| 34 | Hypoplastic labia majora (HP:0000059) | 2.41197766 |
| 35 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.34756639 |
| 36 | Abnormality of the astrocytes (HP:0100707) | 2.34710554 |
| 37 | Astrocytoma (HP:0009592) | 2.34710554 |
| 38 | Chronic hepatic failure (HP:0100626) | 2.28937093 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 2.26869347 |
| 40 | Progressive cerebellar ataxia (HP:0002073) | 2.25350495 |
| 41 | Abnormality of the labia majora (HP:0012881) | 2.25266853 |
| 42 | Autoamputation (HP:0001218) | 2.24001438 |
| 43 | Facial diplegia (HP:0001349) | 2.21343995 |
| 44 | Abnormality of the axillary hair (HP:0100134) | 2.14663538 |
| 45 | Abnormality of secondary sexual hair (HP:0009888) | 2.14663538 |
| 46 | Gaze-evoked nystagmus (HP:0000640) | 2.12980864 |
| 47 | Absent eyelashes (HP:0000561) | 2.12322314 |
| 48 | Abnormality of the fingertips (HP:0001211) | 2.11885917 |
| 49 | Neoplasm of the heart (HP:0100544) | 2.11269161 |
| 50 | Febrile seizures (HP:0002373) | 2.10232330 |
| 51 | Exercise-induced myalgia (HP:0003738) | 2.08529369 |
| 52 | Abnormality of the renal cortex (HP:0011035) | 2.07963914 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06556939 |
| 54 | Dysmetric saccades (HP:0000641) | 2.06259564 |
| 55 | Generalized hypopigmentation of hair (HP:0011358) | 2.05103280 |
| 56 | Conjunctival telangiectasia (HP:0000524) | 2.04904042 |
| 57 | Neoplasm of striated muscle (HP:0009728) | 2.03810076 |
| 58 | Portal hypertension (HP:0001409) | 2.03032722 |
| 59 | Menstrual irregularities (HP:0000858) | 2.02032132 |
| 60 | Abnormality of the ischium (HP:0003174) | 2.01545999 |
| 61 | Abnormality of potassium homeostasis (HP:0011042) | 2.00053623 |
| 62 | Poikilocytosis (HP:0004447) | 1.96424504 |
| 63 | Short chin (HP:0000331) | 1.95672291 |
| 64 | Urinary urgency (HP:0000012) | 1.95652941 |
| 65 | Abnormality of the nasal septum (HP:0000419) | 1.94311024 |
| 66 | Epistaxis (HP:0000421) | 1.94094256 |
| 67 | Broad ribs (HP:0000885) | 1.94054207 |
| 68 | Lip pit (HP:0100267) | 1.92688834 |
| 69 | Atonic seizures (HP:0010819) | 1.92019965 |
| 70 | Curly hair (HP:0002212) | 1.91694548 |
| 71 | Absent eyebrow (HP:0002223) | 1.90184253 |
| 72 | Ventricular tachycardia (HP:0004756) | 1.88797077 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 1.88186024 |
| 74 | Epileptiform EEG discharges (HP:0011182) | 1.88172622 |
| 75 | Asymmetric septal hypertrophy (HP:0001670) | 1.88070615 |
| 76 | Deep philtrum (HP:0002002) | 1.87484443 |
| 77 | Metaphyseal dysplasia (HP:0100255) | 1.87284357 |
| 78 | Hyporeflexia of lower limbs (HP:0002600) | 1.86481590 |
| 79 | Prominent nose (HP:0000448) | 1.85370526 |
| 80 | Submucous cleft hard palate (HP:0000176) | 1.84477568 |
| 81 | Osteolytic defects of the hand bones (HP:0009699) | 1.83737046 |
| 82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83737046 |
| 83 | Hypolipoproteinemia (HP:0010981) | 1.82717923 |
| 84 | Rhabdomyosarcoma (HP:0002859) | 1.82554601 |
| 85 | Myoglobinuria (HP:0002913) | 1.82493345 |
| 86 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.82466344 |
| 87 | Glioma (HP:0009733) | 1.82232712 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 1.81784658 |
| 89 | Spontaneous hematomas (HP:0007420) | 1.80418719 |
| 90 | Hepatoblastoma (HP:0002884) | 1.80407347 |
| 91 | Cone-rod dystrophy (HP:0000548) | 1.80328344 |
| 92 | Drooling (HP:0002307) | 1.78239845 |
| 93 | Decreased lacrimation (HP:0000633) | 1.78211853 |
| 94 | Lower limb amyotrophy (HP:0007210) | 1.77519777 |
| 95 | Increased density of long bones (HP:0006392) | 1.76328256 |
| 96 | Macroorchidism (HP:0000053) | 1.76296569 |
| 97 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.75855932 |
| 98 | Aortic aneurysm (HP:0004942) | 1.74562488 |
| 99 | Hypsarrhythmia (HP:0002521) | 1.74456438 |
| 100 | Anhidrosis (HP:0000970) | 1.74203439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 4.79700684 |
| 2 | CAMK1G | 3.13938926 |
| 3 | CAMK1D | 2.62409970 |
| 4 | CDK12 | 2.57064034 |
| 5 | TAOK3 | 2.53705202 |
| 6 | FRK | 2.51691396 |
| 7 | OBSCN | 2.45944589 |
| 8 | SGK2 | 2.21927529 |
| 9 | MAP3K4 | 2.10759027 |
| 10 | PIK3CG | 2.08012339 |
| 11 | STK39 | 2.07723439 |
| 12 | NLK | 1.83142069 |
| 13 | EPHA3 | 1.76852805 |
| 14 | BRD4 | 1.68272271 |
| 15 | ZAK | 1.67771502 |
| 16 | SGK3 | 1.62180141 |
| 17 | SCYL2 | 1.61988139 |
| 18 | FER | 1.60872267 |
| 19 | MET | 1.57649657 |
| 20 | ACVR1B | 1.56265916 |
| 21 | SGK223 | 1.49493751 |
| 22 | SGK494 | 1.49493751 |
| 23 | CSNK1A1L | 1.49014000 |
| 24 | PIK3CA | 1.44857333 |
| 25 | LATS1 | 1.44417629 |
| 26 | MYLK | 1.40385287 |
| 27 | TLK1 | 1.35558442 |
| 28 | WNK1 | 1.34002541 |
| 29 | MAP4K2 | 1.30665726 |
| 30 | PRKAA2 | 1.30357779 |
| 31 | TEC | 1.30269061 |
| 32 | STK38 | 1.25090916 |
| 33 | MST1R | 1.23402035 |
| 34 | MAP2K7 | 1.20598098 |
| 35 | MST4 | 1.20546639 |
| 36 | BRSK2 | 1.19989356 |
| 37 | CAMKK2 | 1.09090291 |
| 38 | MAP3K2 | 1.07921210 |
| 39 | CSNK1G1 | 1.05844761 |
| 40 | PLK4 | 1.02805992 |
| 41 | PRKAA1 | 1.01442780 |
| 42 | TRPM7 | 0.97002660 |
| 43 | MELK | 0.95900726 |
| 44 | BMPR2 | 0.94974278 |
| 45 | JAK1 | 0.89711365 |
| 46 | CAMK4 | 0.85378510 |
| 47 | BMPR1B | 0.84871010 |
| 48 | FLT3 | 0.84837139 |
| 49 | NUAK1 | 0.83727953 |
| 50 | CAMK1 | 0.82123328 |
| 51 | NTRK3 | 0.82051854 |
| 52 | CSNK1G3 | 0.81494200 |
| 53 | STK3 | 0.80305143 |
| 54 | TIE1 | 0.77713554 |
| 55 | PHKG2 | 0.77490292 |
| 56 | PHKG1 | 0.77490292 |
| 57 | MARK2 | 0.77288640 |
| 58 | CASK | 0.75868124 |
| 59 | ERBB3 | 0.75604813 |
| 60 | DMPK | 0.70361154 |
| 61 | TNIK | 0.69550921 |
| 62 | WNK4 | 0.64099712 |
| 63 | SGK1 | 0.63420220 |
| 64 | INSRR | 0.60537145 |
| 65 | OXSR1 | 0.60505601 |
| 66 | CSNK1G2 | 0.60367588 |
| 67 | PDGFRB | 0.60045035 |
| 68 | CDK6 | 0.57599591 |
| 69 | MAP3K7 | 0.57407980 |
| 70 | PRKD3 | 0.55756546 |
| 71 | RPS6KA5 | 0.55177762 |
| 72 | NEK9 | 0.54719437 |
| 73 | PRKG1 | 0.54267625 |
| 74 | PDK1 | 0.52917435 |
| 75 | PRKCE | 0.52612543 |
| 76 | PTK2B | 0.51596283 |
| 77 | BMX | 0.48884356 |
| 78 | PLK2 | 0.48402557 |
| 79 | PINK1 | 0.46824356 |
| 80 | PAK3 | 0.46679600 |
| 81 | YES1 | 0.46240251 |
| 82 | PKN1 | 0.44667067 |
| 83 | RPS6KA3 | 0.44118388 |
| 84 | MAPK13 | 0.43726167 |
| 85 | NEK6 | 0.43512678 |
| 86 | STK38L | 0.41880719 |
| 87 | PIM1 | 0.41843983 |
| 88 | MAP2K1 | 0.41144224 |
| 89 | MAP3K6 | 0.40395071 |
| 90 | PAK2 | 0.40230251 |
| 91 | MAPK11 | 0.38266923 |
| 92 | MAPK10 | 0.38041902 |
| 93 | CDK3 | 0.36437402 |
| 94 | CSNK1D | 0.36048873 |
| 95 | PRKCB | 0.35846111 |
| 96 | MAP2K4 | 0.34482109 |
| 97 | VRK1 | 0.34064433 |
| 98 | MAPK12 | 0.33483550 |
| 99 | MAPKAPK5 | 0.31395932 |
| 100 | MAPK7 | 0.31380973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Circadian rhythm_Homo sapiens_hsa04710 | 3.03193247 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 3.02143623 |
| 3 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.97089244 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.20517274 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 1.85026717 |
| 6 | Platelet activation_Homo sapiens_hsa04611 | 1.75838422 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.65947140 |
| 8 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.58172731 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57062017 |
| 10 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.54797501 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46722397 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41338493 |
| 13 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.35110412 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.31496952 |
| 15 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26419801 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.24415141 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24187207 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.21573149 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.21308780 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21100128 |
| 21 | Thyroid cancer_Homo sapiens_hsa05216 | 1.20611529 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.18051437 |
| 23 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.15053451 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.14387827 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10610841 |
| 26 | Gap junction_Homo sapiens_hsa04540 | 1.10012234 |
| 27 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.05817127 |
| 28 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.04954853 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.04617578 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03236854 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.01857111 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01055254 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00392754 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99607012 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98395777 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 0.96948041 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95816791 |
| 38 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.95255513 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 0.95108116 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93345028 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92551382 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 0.91955745 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91711516 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 0.91417567 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 0.90052510 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89010871 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 0.88740205 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 0.88020460 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86868333 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86742986 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85468936 |
| 52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84911577 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83978386 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81116827 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.79704575 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79408296 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77902470 |
| 58 | Prostate cancer_Homo sapiens_hsa05215 | 0.77760789 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77405669 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77193164 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76446555 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76228945 |
| 63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76035984 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75565175 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75397665 |
| 66 | Taste transduction_Homo sapiens_hsa04742 | 0.74645988 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.73340818 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72690378 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.72274224 |
| 70 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72239575 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71220303 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68681748 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68084099 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67918840 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67857641 |
| 76 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67568583 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67148995 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66821517 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65203394 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64918049 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63654232 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63496690 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61821149 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60731310 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59777859 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59493560 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58838349 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58683201 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57772625 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57656758 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56891223 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54729473 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54207404 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53262353 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52710214 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52361324 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50413634 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50204526 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47885160 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47654294 |

